Clinical trials
Diabetes Mellitus, Type 1 trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 2 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Unknown status | 7 |
| Completed | 6 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Second Xiangya Hospital of Central South University | 4 |
| Children's Hospital of Fudan University | 2 |
| Medtronic MiniMed, Inc. | 2 |
| Huashan Hospital | 1 |
| Peking Union Medical College Hospital | 1 |
| Peking University First Hospital | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Shanghai 6th People's Hospital | 1 |
| Sun Yat-sen University | 1 |
| Suzhou Hechun Medical Technology Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 23 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Autoimmune Diseases | 2 |
| Cognitive Dysfunction | 1 |
| Diabetes, Gestational | 1 |
| Endocrine System Diseases | 1 |
| Glucose Metabolism Disorders | 1 |
| Immune System Diseases | 1 |
| Immunologic Deficiency Syndromes | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.